Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xingrui Biological Technology is a Chinese industrial biotechnology company specializing in the production of bio-based ingredients for the food, beverage, and pharmaceutical industries. The company is a leading manufacturer of erythritol, a natural zero-calorie sweetener, as well as sodium gluconate and glucono-delta-lactone. Headquartered in Binzhou, Shandong Province, the firm utilizes advanced microbial fermentation and purification technologies to produce high-purity biochemicals. Its facilities adhere to international quality standards, including GMP and ISO certifications, allowing it to serve a global customer base. While the company does not maintain a clinical drug pipeline, it is a critical supplier of functional sugar alcohols and pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xingrui Biological Technology.